These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3958924)

  • 1. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of pentoxifylline pharmacokinetics by cimetidine.
    Mauro VF; Mauro LS; Hageman JH
    J Clin Pharmacol; 1988 Jul; 28(7):649-54. PubMed ID: 3216031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of intravenous and oral pentoxifylline in healthy subjects.
    Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A
    Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of carbamazepine metabolism by cimetidine.
    Grasela DM; Rocci ML
    Drug Metab Dispos; 1984; 12(2):204-8. PubMed ID: 6144486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)].
    Schaefer K; von Herrath D; Hensel A; Grigoleit HG
    Med Klin; 1977 Feb; 72(6):204-6. PubMed ID: 840136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The excretion of pentoxifylline and its metabolites into human breast milk.
    Witter FR; Smith RV
    Am J Obstet Gynecol; 1985 Apr; 151(8):1094-7. PubMed ID: 3985069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood.
    Grasela DM; Rocci ML
    J Chromatogr; 1987 Aug; 419():368-74. PubMed ID: 3667793
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of orally administered pentoxifylline in humans.
    Smith RV; Waller ES; Doluisio JT; Bauza MT; Puri SK; Ho I; Lassman HB
    J Pharm Sci; 1986 Jan; 75(1):47-52. PubMed ID: 3958905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of pentoxifylline and its hydroxy metabolite in human plasma.
    Garnier-Moiroux A; Poirier JM; Cheymol G; Jaillon P
    J Chromatogr; 1987 Apr; 416(1):183-8. PubMed ID: 3597635
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite following intravenous administration in cattle.
    Uney K; Tras B; Corum O; Yildiz R; Maden M
    Trop Anim Health Prod; 2019 Feb; 51(2):435-441. PubMed ID: 30219998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of pentoxifylline during concomitant theophylline administration to rats.
    Rocci ML; Luke DR; Saccar CL
    Pharm Res; 1987 Oct; 4(5):433-5. PubMed ID: 3508555
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
    Bryce TA; Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion.
    Ings RM; Nüdemberg F; Burrows JL; Bryce TA
    Eur J Clin Pharmacol; 1982; 23(6):539-43. PubMed ID: 7160423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of cimetidine on elimination and distribution of propranolol in rats.
    Shibasaki S; Asahina M; Kawamata Y; Kojo M; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Sep; 12(9):549-57. PubMed ID: 2614643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.
    Mojaverian P; Rocci ML; Saccar CL; Vlasses PH; Ferguson RK
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):155-9. PubMed ID: 2864251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of pentoxifylline and its 5-hydroxy metabolite in human plasma by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Musch G; Hamoir T; Massart DL
    J Chromatogr; 1989 Oct; 495():215-26. PubMed ID: 2613806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.